AC IMMUNE SA SF-02 Cash Flow Reinvestment Rate
AC IMMUNE SA SF-02 cash flow reinvestment rate. AC IMMUNE SA SF-02 (IMR) has a Cash Flow Reinvestment Rate of 0.64x as of December 2024, reinvesting €3.83 Million (capex €90.00K plus investments €-3.74 Million) from operating cash flow of €5.93 Million. Explore debt repayment capacity of AC IMMUNE SA SF-02 to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of AC IMMUNE SA SF-02 (2024–2024)
Cash flow reinvestment rate of AC IMMUNE SA SF-02 from 2024 to 2024. Historical reinvestment intensity for AC IMMUNE SA SF-02 across 1 annual periods. Explore capital reinvestment ratio of AC IMMUNE SA SF-02 to see what proportion of operating cash flow is directed to capital expenditures.
AC IMMUNE SA SF-02 Cash Flow Reinvestment Rate by Year (2024–2024)
AC IMMUNE SA SF-02 cash flow reinvestment rate by year from 2024 to 2024. Year-by-year capital reinvestment analysis for AC IMMUNE SA SF-02. For the full cash flow conversion analysis, see cash efficiency ratio of AC IMMUNE SA SF-02.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.60x | €105.24 Million | €65.84 Million | €576.00K | — |